NEJM AI

@NEJM_AI

NEJM AI is a new journal on medical artificial intelligence and machine learning from NEJM Group, the publisher of @NEJM.

Boston ai.nejm.org Joined November 2022

330 Following 14K Followers 1.7K Posts

Latest posts 5

Pinned post

NEJM AI @NEJM_AI Oct 21

On AI Grand Rounds, Dr. Michal Nedoszytko (@mnedoszytko) explains how AI can help physicians gather better information, improve the quality of conversations with patients, and prototype solutions to problems that clinicians experience every day. 🎧 nejm.ai/ep47

Promotional image for episode 47 of the NEJM AI Grand Rounds podcast featuring Dr. Michal Nedoszytko. The left side includes the title: "Abridge’s Dr. Michal Nedoszytko on Physicians Who Build Software." A photo of Dr. Nedoszytko is on the right.

NEJM AI @NEJM_AI 2d

What if AI improved the visit before it began? On @NEJM_AI Grand Rounds, Dr. Michal Nedoszytko (@mnedoszytko) explains how pre-visit conversations help patients arrive prepared, improving the quality of the clinician-patient encounter. Listen now: nejm.ai/ep47

0:21

NEJM AI @NEJM_AI 4d

Perspective by E. Kim et al.: Clinical AI in 2025–2026 — Six Themes from the SAIL Year in Review nejm.ai/4ilMIfD

#ArtificialIntelligence #AIinMedicine

The image is page 1 of the Perspective "Clinical AI in 2025–2026 — Six Themes from the SAIL Year in Review" published in NEJM AI. An orange banner at the bottom encourages readers to access the full Perspective at ai.nejm.org.

NEJM AI @NEJM_AI 5d

Start with the friction clinicians actually experience. On @NEJM_AI Grand Rounds, Dr. @mnedoszytko says living inside the problem can reveal what needs fixing — and why physicians may be well positioned to build a useful solution for care. Full episode: nejm.ai/ep47

0:27

NEJM AI @NEJM_AI 6d

An AI-assisted molecular synthesis workflow integrating multimodal molecular data guided an unproven treatment decision in a diagnostically ambiguous case of adult sonic hedgehog–activated medulloblastoma. Learn more: nejm.ai/4yVI65V

Four panels show brain MRI of patient with SHH medulloblastoma before and 3 months after Pretreatment T1-weighted postcontrast (Panel A) and FLAIR postcontrast (Panel B) images show a heterogeneously enhancing cerebellar mass. Follow-up T1-weighted postcontrast (Panel C) and FLAIR postcontrast (Panel D) images demonstrate substantial interval decrease in lesion size with minimal residual enhancement and persistent FLAIR hyperintensity.